On average, drugs developed for central nervous system (CNS, brain and spinal cord ... target such receptors in order to use them to usher vector-associated drugs across the BBB into the nervous ...

Orchard Therapeutics, a Kyowa Kirin company, today announced presentations from seven abstracts from across its hematopoietic stem cell (HSC) gene therapy portfolio will be featured at the 21st Annual ...

During the summer, it is a leading cause of central nervous system infections ... are suspected to influence vector activity and disease transmission, but the specific impacts on TOSV dynamics ...

Choose from Central Nervous System Illustration stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature ...

Choose from Nervous System Diagram stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection ...

PARIS, France I February 12, 2025 I GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and ...

Researchers have demonstrated, for the first time in the world using mice, the ability to overcome significant challenges in ...

The country’s elimination of human African trypanosomiasis brings the total to 55 countries that have eliminated at least one ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

India experiences the world’s absolute burden of at least 11 NTDs, including hookworm, dengue, lymphatic filariasis, leprosy, kala-azar, and rabies, representing the highest number of cases worldwide ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's results. Click for this VYGR update.